Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-30

Clinical Trial Update: Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment [NA]

View source ↗

Summary

Ongoing recruiting study evaluating whether exercise and body composition optimization can prevent muscle loss in people treated with a GLP-1 receptor agonist f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Obesity, Body Composition | NA | Status: RECRUITING